PCNA, which is an antigen characteristic of proliferating cells that is expressed in cell nuclei during the S phase of the cell cycle, is a widely recognized cell proliferation marker that also serves as a prognostic indicator for a variety of tumors, including glioma (23). This evidence concerns the gene PCNA and central nervous system cancer.